SCA
CVS icon

Spearhead Capital Advisors’s CVS Health CVS Stock Holding History

Spearhead Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$883K Sell
9,255
-88,460
-91% -$8.76M 0.96% 38
2022
Q2 		$9.05M Sell
97,715
-10,075
-9% -$983K 1.35% 30
2022
Q1 		$10.9M Sell
107,790
-11,422
-10% -$1.2M 1.35% 26
2021
Q4 		$12.3M Buy
119,212
+2,126
+2% +$196K 1.48% 20
2021
Q3 		$9.94M Sell
117,086
-1,593
-1% -$133K 1.32% 22
2021
Q2 		$9.9M Buy
118,679
+647
+0.5% +$53K 1.35% 21
2021
Q1 		$8.88M Buy
118,032
+21,418
+22% +$1.56M 1.31% 23
2020
Q4 		$6.6M Buy
96,614
+6,608
+7% +$430K 1.05% 44
2020
Q3 		$5.26M Buy
90,006
+4,251
+5% +$265K 1% 46
2020
Q2 		$5.57M Buy
85,755
+4,387
+5% +$276K 1.19% 32
2020
Q1 		$4.83M Buy
81,368
+12,655
+18% +$845K 1.39% 29
2019
Q4 		$5.11M Buy
68,713
+2,068
+3% +$145K 1.27% 36
2019
Q3 		$4.2M Buy
66,645
+6,439
+11% +$382K 1.17% 51
2019
Q2 		$3.28M Buy
+60,206
New +$3.24M 0.96% 56

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Spearhead Capital Advisors's CVS Position: Q3 2022 in Review

Spearhead Capital Advisors reduced its CVS Health (CVS) stake by 91% in Q3 2022, selling an estimated $8.76M and leaving 9,255 shares worth $883K. The position accounts for 0.96% of the portfolio, ranked #38.

Spearhead Capital Advisors first reported a position in CVS in Q2 2019 and has held it in 14 quarters since. The position peaked at $12.3M in Q4 2021. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Spearhead Capital Advisors held 9,255 shares of CVS Health worth $883K as of Q3 2022.
  • Spearhead Capital Advisors sold 88,460 CVS Health shares in Q3 2022, an estimated $8.76M.
  • CVS Health made up 0.96% of Spearhead Capital Advisors's portfolio in Q3 2022, its #38 holding.
  • Spearhead Capital Advisors first reported a position in CVS Health in Q2 2019 and has held it in 14 quarters since.
  • Spearhead Capital Advisors's CVS Health position peaked at $12.3M in Q4 2021.
  • 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.